Copyright
©The Author(s) 2021.
World J Stem Cells. Jan 26, 2021; 13(1): 78-90
Published online Jan 26, 2021. doi: 10.4252/wjsc.v13.i1.78
Published online Jan 26, 2021. doi: 10.4252/wjsc.v13.i1.78
Figure 2 Purification and identification of adenoviral-glial cell line-derived neurotrophic factor.
A: Adenoviral-glial cell line-derived neurotrophic factor (Ad-GDNF) bands after CsCl ultracentrifugation; B: Identification of the correct 205 bp GDNF gene in Ad-GDNF; C: GDNF mRNA level was enhanced in Ad-GDNF-infected cultures compared to mock (Adpgk)-infected cultures; D: Neuronal connections were increased in Ad-GDNF-infected cultures compared to control cultures. Ad-GDNF: Adenoviral-glial cell line-derived neurotrophic factor; PCR: Polymerase chain reaction; IR: Immunoreactive.
- Citation: Tsai MJ, Hung SC, Weng CF, Fan SF, Liou DY, Huang WC, Liu KD, Cheng H. Stem cell transplantation and/or adenoviral glial cell line-derived neurotrophic factor promote functional recovery in hemiparkinsonian rats. World J Stem Cells 2021; 13(1): 78-90
- URL: https://www.wjgnet.com/1948-0210/full/v13/i1/78.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v13.i1.78